Search results
Understanding the Beta Thalassemia Minor Trait
Verywell Health via Yahoo News· 10 months agoBeta thalassemia minor—also known as beta thalassemia trait or B thalassemia—is a blood disorder. It lowers your blood's level of hemoglobin, an...
Thalassemia: Understanding This Inherited Blood Disorder
Verywell Health via Yahoo News· 10 months agoThalassemia is a group of blood disorders in which the body doesn't make enough hemoglobin, the...
What Is Beta Thalassemia?
Health via Yahoo News· 4 months agoBeta thalassemia is a blood disorder affecting the production of hemoglobin, the iron-rich protein in red blood cells that carries oxygen through the...
1 Setback and 1 Opportunity for CRISPR Therapeutics Stock
Motley Fool via Yahoo Finance· 5 months agoWith CRISPR Therapeutics (NASDAQ: CRSP) in the news thanks to its successful work in developing...
Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development
InvestorPlace via Yahoo Finance· 6 months agoThe pharma stock leaders can at times seem overly risk averse with their approach to developing new...
4 First-in-Their-Class Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market...
Motley Fool· 7 months agoWhen looked at over multiple decades, it's difficult to find a more consistent moneymaker than the...
Beat the Dow Jones With CRISPR Therapeutics Stock
Motley Fool· 1 year agoBack in 2020, CRISPR Therapeutics (NASDAQ: CRSP) left the Dow Jones Industrial Average (DJIA) in the dust. The stock soared more than 150%, while the...
Wall Street Estimates That CRISPR Therapeutics Stock Could Jump 49%. Here's Why That's Right.
Motley Fool· 12 months agoIf the consensus price target set by Wall Street analysts is to be believed, CRISPR Therapeutics...
Down 51% in 2023, Here's Why Bluebird Bio Stock Could Soon Double, Says Wall Street
Motley Fool· 12 months agoWall Street analysts' opinions are often well worth considering, but should the small investor...
3 Monster Stocks in the Making to Buy Right Now
Motley Fool· 2 years agoHere's why they chose CRISPR Therapeutics (NASDAQ: CRSP), Ginkgo Bioworks (NYSE: DNA), and Novocure (NASDAQ: NVCR). Prosper Junior Bakiny (CRISPR Therapeutics): Despite tremendous medical progress ...